NNMTi - Selective NNMT Inhibitor for Research / Articles

Introduction

Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme that catalyzes the N-methylation of nicotinamide using S-adenosylmethionine (SAM) as a methyl donor, producing 1-methylnicotinamide (MNA) and S-adenosylhomocysteine. Elevated NNMT activity has been implicated in a wide range of pathological conditions, including metabolic disorders (obesity, type 2 diabetes), various cancers, and inflammatory processes, making it an attractive therapeutic target. NNMTi (CAS 42464-96-0) is a small-molecule, substrate-competitive inhibitor that selectively targets the NNMT substrate-binding site. By inhibiting NNMT activity, NNMTi modulates cellular methylation balance and NAD⁺ levels, impacting energy metabolism, cellular aging, and differentiation processes. This article provides a comprehensive overview of the structural characteristics, synthesis, physicochemical properties, and research applications of this promising molecular probe.

Chemical Structure and Synthesis

NNMTi (5-amino-1-methylquinolinium iodide) is a synthetic organic compound with the molecular formula C₁₀H₁₁IN₂ and a molecular weight of 286.11 g/mol. The molecule features a quinolinium core, a methyl group at the 1-position, and an amino group at the 5-position. This structural organization provides an aromatic system that mimics the natural substrate nicotinamide, enabling competitive binding to the active site of NNMT. The iodide counterion enhances crystallinity and solubility in polar solvents. Synthesis of NNMTi proceeds through a multi-step organic synthesis route, typically involving the alkylation of 5-aminoquinoline with methyl iodide under controlled conditions, followed by purification via recrystallization or chromatographic techniques. Modern synthetic methods ensure high purity (typically ≥98–99 %) and batch-to-batch consistency required for biological research applications.

Physical and Chemical Properties

NNMTi CAS 42464-96-0 is characterized by the following physicochemical properties:

Appearance: White to off-white crystalline powder
Molecular Weight: 286.11 g/mol
Purity: Typically ≥98 % (HPLC)
Solubility: Soluble in DMSO (57 mg/mL), water (5–7 mg/mL), and ethanol (3 mg/mL)
Stability: Stable for up to 3 years when stored as a powder at –20 °C, protected from light and moisture
IC₅₀: 1.2 µM (in biochemical assays with 50 µM SAM and 100 µM NCA)
Cellular Activity: Reduces MNA levels (EC₅₀ = 2.3 µM) and suppresses lipogenesis (EC₅₀ = 30 µM) in adipocytes
Selectivity: No reported interaction with related methyltransferases or NAD⁺ salvage pathway enzymes

Mechanism of Action

NNMTi functions as a substrate-competitive inhibitor that selectively binds to residues within the NNMT substrate-binding site. By competing with the natural substrate nicotinamide, NNMTi effectively blocks the methylation of nicotinamide to 1-methylnicotinamide (MNA). This inhibition leads to several downstream effects:

Reduction of MNA levels: In cellular models, NNMTi treatment reduces MNA levels with an EC₅₀ of 2.3 µM.
Modulation of NAD⁺ metabolism: By conserving nicotinamide, NNMTi may influence NAD⁺ salvage pathway activity.
Suppression of lipogenesis: In 3T3-L1 adipocytes, NNMTi reduces lipogenesis with an EC₅₀ of 30 µM.
Promotion of myoblast differentiation: NNMTi enhances myoblast differentiation in vitro and improves muscle stem cell (muSC) fusion and regenerative capacity in aged mice.

Applications

NNMTi serves as a valuable tool in several areas of biomedical research:

Metabolic Disorder Research: NNMTi is used to investigate the role of NNMT in obesity, type 2 diabetes, and related metabolic syndromes. It helps elucidate the connection between NNMT activity, nicotinamide metabolism, and adipocyte function.
Cancer Research: Given the association of NNMT overexpression with various cancers, NNMTi is employed to study the role of NNMT in tumor metabolism and proliferation. In vivo studies have demonstrated that NNMTi (10–40 mg/kg, intraperitoneal administration) can modulate tumor growth in xenograft models.
Muscle Regeneration and Aging Research: NNMTi has been shown to rescue age-related deficits in muscle stem cell activity. In aged mice, NNMTi treatment significantly improves muscle regeneration after injury, enhancing myofiber cross-sectional area and increasing peak torque by up to 70 % compared to controls.
In Vitro and In Vivo Studies: As a well-characterized chemical probe, NNMTi is widely used in cell-based assays and animal models to dissect NNMT-mediated signaling pathways and evaluate the therapeutic potential of NNMT inhibition.

Safety and Toxicology

NNMTi is intended for research use only and is not approved for human therapeutic applications. Key safety considerations include:

Toxicity: Limited toxicological data are available; standard laboratory safety practices should be observed.
Handling: Avoid inhalation, ingestion, and skin or eye contact. Use appropriate personal protective equipment (PPE) including gloves, safety goggles, and a lab coat.
Storage: Store as a powder at –20 °C under dry, dark conditions to maintain stability.
Disposal: Dispose of in accordance with local environmental and institutional regulations.

Storage and Handling

To maintain product integrity and ensure safe use:

Temperature: Store powder at –20 °C for long-term stability (up to 3 years).
Protection: Protect from light and moisture.
Solubility: Prepare stock solutions in DMSO (57 mg/mL) or water (5–7 mg/mL); use freshly opened DMSO to avoid reduced solubility due to moisture absorption.
Incompatibilities: Avoid contact with strong oxidizing agents.
Spills: Collect mechanically; dispose of as hazardous waste according to local regulations.

Conclusion

NNMTi (CAS 42464-96-0) is a potent, selective, substrate-competitive inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme with significant implications in metabolic disorders, cancer, and aging. With an IC₅₀ of 1.2 µM and demonstrated efficacy in both cellular and in vivo models, NNMTi serves as an invaluable research tool for elucidating NNMT biology and evaluating the therapeutic potential of NNMT inhibition. Its well-characterized physicochemical properties, including high solubility in DMSO and stability at –20 °C, facilitate its use in a wide range of experimental settings. As research into NNMT-mediated pathways continues to expand, NNMTi will remain a key probe for investigating the role of nicotinamide methylation in health and disease.